iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
9.98
+0.03 (0.25%)
At close: Jun 30, 2025, 4:00 PM
9.97
0.00 (-0.05%)
After-hours: Jun 30, 2025, 4:00 PM EDT
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $381.78 million as of June 30, 2025. Its market cap has decreased by -37.23% in one year.
Market Cap
381.78M
Enterprise Value
-133.53M
1-Year Change
-37.23%
Ranking
Category
Stock Price
$9.98
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $381.78M, a decrease of -40.06%. That is a compound annual growth rate of -9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 380.82M | 35.73% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |